| Name | Disitertide |
|---|---|
| Synonyms |
Disitertide,P144,P144 Ptide
P144 Ptide L-Aspagine,L-threonyl-L-seryl-L-leucyl-L-a-asptyl-L-alanyl-L-seryl-L-isoleucyl-L-isoleucyl-L-tryptophyl-L-alanyl-L-methionyl-L-methionyl-L-glutaminyl L-Aspagine, L-threonyl-L-seryl-L-leucyl-L-α-asptyl-L-alanyl-L-seryl-L-isoleucyl-L-isoleucyl-L-tryptophyl-L-alanyl-L-methionyl-L-methionyl-L-glutaminyl DisitertideH-Gly-g-Gly-Asp-Asn-Pro-OH P144;P144 PTIDE DISITERTIDE tsldasiiwammqn TSLDASIIWAMMQN L-Threonyl-L-seryl-L-leucyl-L-alpha-asptyl-L-alanyl-L-seryl-L-isoleucyl-L-isoleucyl-L-tryptophyl-L-alanyl-L-methionyl-L-methionyl-L-glutaminyl-L-aspagine |
| Description | Disitertide is an inhibitor of TGF-β1. Sequence: Thr-Ser-Leu-Asp-Ala-Ser-Ile-Ile-Trp-Ala-Met-Met-Gln-Asn. |
|---|---|
| Related Catalog | |
| In Vitro | Disitertide (P144) prevents TGF-β1-dependent inhibition of MV1Lu proliferation in vitro and markedly reduces binding of TGF-β1 to its receptors. Disitertide blocks TGF-β1-dependent stimulation of a reporter gene under the control of human α2(I) collagen promoter[1]. |
| In Vivo | Treatment with Disitertide at low doses causes a significant inhibition of HSC activation and a marked reduction in liver fibrosis in a rat model of chronic exposure to CCl4. A dose as low as 70 μg of the 15-mer peptide Disitertide, given to rats (300 g body weight) on alternate days, decreases fibrogenesis significantly during chronic exposure to CCl4[1]. |
| References |
| Density | 1.327g/cm3 |
|---|---|
| Boiling Point | 1968.718ºC at 760 mmHg |
| Molecular Formula | C68H109N17O22S2 |
| Molecular Weight | 1580.82000 |
| Exact Mass | 1579.74000 |
| PSA | 692.18000 |
| LogP | 1.27260 |
| Storage condition | -20°C |